A. D. Beadell Investment Counsel, Inc. Pfizer Inc Transaction History
A. D. Beadell Investment Counsel, Inc.
- $115 Million
- Q1 2024
A detailed history of A. D. Beadell Investment Counsel, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, A. D. Beadell Investment Counsel, Inc. holds 25,581 shares of PFE stock, worth $708,593. This represents 0.62% of its overall portfolio holdings.
Number of Shares
25,581
Previous 23,031
11.07%
Holding current value
$708,593
Previous $663,000
6.94%
% of portfolio
0.62%
Previous 0.63%
Shares
18 transactions
Others Institutions Holding PFE
# of Institutions
3,158Shares Held
3.68BCall Options Held
67.4MPut Options Held
113M-
Vanguard Group Inc Valley Forge, PA507MShares$14.1 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY431MShares$11.9 Billion0.28% of portfolio
-
State Street Corp Boston, MA291MShares$8.05 Billion0.37% of portfolio
-
Wellington Management Group LLP Boston, MA178MShares$4.92 Billion0.89% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA122MShares$3.39 Billion0.79% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $155B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...